| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.49▼ | 4.50▼ | 4.50▼ | 4.38▲ | 4.68▼ |
| MA10 | 4.50▼ | 4.49▼ | 4.39▲ | 4.42▲ | 5.04▼ |
| MA20 | 4.51▼ | 4.37▲ | 4.31▲ | 4.60▼ | 5.83▼ |
| MA50 | 4.50▼ | 4.35▲ | 4.44▲ | 5.11▼ | 5.70▼ |
| MA100 | 4.40▲ | 4.48▼ | 4.42▲ | 5.84▼ | 5.71▼ |
| MA200 | 4.31▲ | 4.45▲ | 4.88▼ | 5.71▼ | 4.92▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | 0.015▲ | 0.038▲ | 0.021▲ | -0.218▼ |
| RSI | 43.190▼ | 58.784▲ | 57.249▲ | 43.649▼ | 36.722▼ |
| STOCH | 19.697▼ | 70.160 | 81.669▲ | 22.820 | 12.663▼ |
| WILL %R | -81.818▼ | -25.000▲ | -22.892▲ | -70.000 | -85.841▼ |
| CCI | -197.647▼ | 43.411 | 83.624 | -2.037 | -111.681▼ |
|
Friday, November 14, 2025 07:51 AM
ABEO READ THE FULL ABEO RESEARCH REPORT Business Update First Patient Treated with Zevaskyn® Pushed to 4Q25 The first patient treated with Zevaskyn was pushed back to the fourth quarter of 2025 ...
|
|
Thursday, November 13, 2025 05:16 AM
Operator: Good morning, everyone. And welcome to the Abeona Therapeutics third quarter 2025 conference call. At this time, all participants are in a listen-only mode.
|
|
Wednesday, November 12, 2025 01:00 PM
Abeona Therapeutics Inc (ABEO) reports significant progress in ZivaSkin's commercial launch and market access, despite facing delays in patient treatments and a decrease in R&D spending.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/11/25 | 4.21 | 4.57 | 4.19 | 4.48 | 1,813,882 |
| 20/11/25 | 4.21 | 4.35 | 4.16 | 4.22 | 1,843,228 |
| 19/11/25 | 4.47 | 4.47 | 4.16 | 4.20 | 2,073,227 |
| 18/11/25 | 4.48 | 4.58 | 4.395 | 4.48 | 1,545,817 |
| 17/11/25 | 4.41 | 4.625 | 4.39 | 4.51 | 2,112,209 |
| 14/11/25 | 4.50 | 4.59 | 4.37 | 4.45 | 2,636,100 |
| 13/11/25 | 4.90 | 4.91 | 4.49 | 4.53 | 4,487,900 |
| 12/11/25 | 4.535 | 5.60 | 4.53 | 4.94 | 12,312,298 |
| 11/11/25 | 4.24 | 4.33 | 4.12 | 4.17 | 2,902,178 |
| 10/11/25 | 4.25 | 4.33 | 4.065 | 4.23 | 2,407,265 |
|
|
||||
|
|
||||
|
|